BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31765356)

  • 1. Survival differences between definitive radiotherapy and surgery followed by adjuvant radiotherapy in supraglottic and hypopharyngeal carcinoma.
    Zhang M; Gao XS; Qin Y; Sun Y; Ma MW
    Chin Med J (Engl); 2019 Nov; 132(22):2698-2704. PubMed ID: 31765356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
    Li ZD; Lu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
    [No Abstract]   [Full Text] [Related]  

  • 3. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
    Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
    Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
    Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
    Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
    Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
    Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
    Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
    Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
    Kuo P; Sosa JA; Burtness BA; Husain ZA; Mehra S; Roman SA; Yarbrough WG; Judson BL
    Cancer; 2016 Jun; 122(12):1853-60. PubMed ID: 27019213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
    Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of combined radiotherapy with EGFR inhibitors and chemotherapy for laryngeal organ preservation in patients with locally advanced hypopharyngeal carcinomas.
    Zhang X; Wang J; Wu W; Liu M; Zhao F; Du L; Huang D; Yang S; Ma L
    Curr Cancer Drug Targets; 2014; 14(6):589-98. PubMed ID: 25039274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with locally advanced hypopharyngeal carcinoma. Results over a 30-year period.
    León X; López M; García J; Rovira C; Casasayas M; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(6):315-326. PubMed ID: 30527320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changing trend in prognosis of primary hypopharyngeal carcinoma and reason analysis: date comparison of 2003-2007 and 2010-2014 in a single centre].
    Tao L; Zhou L; Zhang M; Wu HT; Li XM; Chen XL; Li C; Xie M; Cheng L; Heng Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 55(2):116-124. PubMed ID: 32074749
    [No Abstract]   [Full Text] [Related]  

  • 16. Multi-modality management for loco-regionally advanced laryngeal and hypopharyngeal cancer: balancing the benefit of efficacy and functional preservation.
    Qian W; Zhu G; Wang Y; Wang X; Ji Q; Wang Y; Dou S
    Med Oncol; 2014 Sep; 31(9):178. PubMed ID: 25131963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of postoperative adjuvant radiotherapy and postoperative concurrent chemoradiotherapy for locally advanced hypopharyngeal squamous cell carcinoma].
    Liu K; Zhang XX; Liu MB; Wang JL; Wu WM; Huang DL; Zhao JD; Ma L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 54(9):662-669. PubMed ID: 31550757
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
    Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.